Cipla Moving Away From Reliance On Sales Of ARVs In Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
Cipla, a major producer of antiretroviral drugs, is bowing to increased competition from both local and foreign drug makers for the treatments in emerging markets such as Africa that the firm relies on for sales.